Gated technetium-99m methoxy-isobutylisonitrile perfusion imaging

Area of Science:

• Nuclear Medicine
• Cardiology
• Diagnostic Imaging

Background:

• Technetium-99m methoxy-isobutylisonitrile (MIBI) is a myocardial perfusion imaging agent.
• Coronary artery disease (CAD) detection relies on accurate perfusion assessment.
• Gated imaging may reduce motion artifacts and improve diagnostic sensitivity.

Purpose of the Study:

• To compare the diagnostic performance of gated end-diastolic versus ungated myocardial perfusion imaging for CAD detection.
• To evaluate the impact of gating on the sensitivity and specificity of technetium-99m MIBI imaging.

Main Methods:

• 46 subjects underwent technetium-99m MIBI myocardial perfusion imaging.
• Perfusion images were analyzed from the whole cardiac cycle (ungated) and end-diastolic frames (gated).
• Diagnostic accuracy for CAD was assessed by comparing imaging results with coronary angiography findings.

Main Results:

• No significant difference in overall patient detection between ungated (25/31) and end-diastolic gated images (28/31).
• Significant improvement in detecting perfusion defects in the left anterior descending (17/20 gated vs 11/20 ungated) and right coronary artery territories (16/21 gated vs 10/21 ungated).
• Overall improvement in detecting regions supplied by stenosed arteries: 45/55 with end-diastolic gating versus 31/55 ungated (P < 0.01).

Conclusions:

• End-diastolic frame selection in technetium-99m MIBI myocardial perfusion imaging significantly enhances diagnostic capacity.
• Gated acquisition improves the detection of regional myocardial perfusion abnormalities in patients with coronary artery disease.
• This technique offers a valuable improvement for the non-invasive diagnosis of coronary artery disease.